Moderna
MRNA
#278
Rank
NZ$158.71 B
Marketcap
NZ$392.26
Share price
-3.63%
Change (1 day)
799.28%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2026 (TTM): NZ-$13.90

According to Moderna 's latest financial reports the company's current EPS (TTM) is NZ-$14.56. In 2025 the company made an earnings per share (EPS) of NZ-$13.25 an increase over its 2024 EPS that were of NZ-$16.91.

EPS history for Moderna from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$13.904.94%
2025NZ-$13.25-21.66%
2024NZ-$16.91-25.04%
2023NZ-$22.56-158.62%
2022NZ$38.48-30.25%
2021NZ$55.18-1660.82%
2020NZ-$3.5425.32%
2019NZ-$2.8236.87%
2018NZ-$2.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.17-183.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.57-165.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$1.81-112.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ-$1.33-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ-$3.70-74.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$36.10-347.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ-$6.07-58.32%๐Ÿ‡บ๐Ÿ‡ธ USA